Pharmacokinetics, Efficacy, Tolerability and Safety of a New Subcutaneous Human Immunoglobulin 16.5% in Primary Immune Deficiency

被引：0

作者：

Kobayashi, Roger ^{[1
]}

Gupta, Sudhir ^{[2
,3
]}

Melamed, Isaac R. ^{[4
]}

Mandujano, Jose F. ^{[5
]}

Kobayashi, Ai Lan ^{[6
]}

Ritchie, Bruce ^{[7
]}

Turpel-Kantor, Eva ^{[8
]}

Litzman, Jiri ^{[9
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA

[2] Univ Calif Irvine, Pathol & Lab Med, Med, Irvine, CA USA

[3] Univ Calif Irvine, Microbiol & Mol Genet, Irvine, CA USA

[4] IMMUNOe Res Ctr Centennial, Denver, CO USA

[5] Pediat Pulm Associates North TX, Frisco, PA USA

[6] Midlands Pediat, Papillion, NE 68046 USA

[7] Univ Alberta, Div Hematol, Dept Med, Fac Med & Dent, Edmonton, AB, Canada

[8] Octapharma Pharmazeutika Produktionsges MbH, Immunol, Vienna, Austria

[9] St Annes Univ Hosp, Dept Clin Immunol Allergol, Immunol, Brno, Czech Republic

来源：

JOURNAL OF CLINICAL IMMUNOLOGY | 2018年 / 38卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

128

引用

页码：391 / 392

页数：2

共 50 条

[31] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20%: INTERIM ANALYSIS OF A PHASE 2/3 STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
Krivan, Gergely
Borte, Michael
Marodi, Laszlo
Derfalvi, Beata
Dicso, Ferenc
Engl, Werner
Leibl, Heinz
McCoy, Barbara
Schiff, Richard I.
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 728 - 728
[32] Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America
Daniel Suez
Mark Stein
Sudhir Gupta
Iftikhar Hussain
Isaac Melamed
Kenneth Paris
Amy Darter
Christelle Bourgeois
Sandor Fritsch
Heinz Leibl
Barbara McCoy
David Gelmont
Leman Yel
Journal of Clinical Immunology, 2016, 36 : 700 - 712
[33] SAFETY/TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
Paris, K.
Derfalvi, B.
Hussain, I.
Haddad, E.
Dicso, F.
Darter, A.
Doralt, J.
Engl, W.
Mccoy, B.
Yel, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S97 - S97
[34] Efficacy and Tolerability of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Neurologic Diseases
Chen, Yun
Wang, Chunyu
Xu, Fanxi
Ming, Fengyu
Zhang, Hainan
CLINICAL THERAPEUTICS, 2019, 41 (10) : 2112 - 2136
[35] TOLERABILITY OF A NEW HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% PREPARATION IN PRIMARY IMMUNODEFICIENCY DISEASES
Gupta, S.
Stein, M.
Melamed, I.
Hussain, I.
Paris, K.
Engl, W.
Mccoy, B.
Rabbat, C.
Yel, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S5 - S6
[36] Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency
Gupta, Sudhir
Kobayashi, Roger H.
Litzman, Jiri
Cherwin, Laurel
Hoeller, Sonja
Kreuwel, Huub
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 7 - 17
[37] Clinical Studies Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of a New Human Plasma-Derived Intravenous Immunoglobulin Product ("NEWGAM 10%") in Patients with Primary Immunodeficiency Disease
Borte, M.
Wietek, S.
Pyringer, B.
Svae, T. E.
Moy, J.
Melamed, I.
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S304 - S304
[38] Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
Suez, Daniel
Krivan, Gergely
Jolles, Stephen
Stein, Mark
Gupta, Sudhir
Paris, Kenneth
van Hagen, P. Martin
Brodszki, Nicholas
Engl, Werner
Leibl, Heinz
McCoy, Barbara
Yel, Leman
IMMUNOTHERAPY, 2019, 11 (12) : 1057 - 1065
[39] Efficacy, Pharmacokinetics and Safety of I10, a Novel 10 % Intravenous Immunoglobulin in Patients with Primary Immune Deficiency (PID): a Prospective Multicentre Study
Krivan, Gergely
Chernyshova, Ludmila
Kostyuchenko, Larysa
Lange, Andrzej
Nyul, Zoltan
Derfalvi, Beata
Musial, Jacek
Bellon, Anne
Kappler, Martin
Sadoun, Alain
Bernatowska, Ewa
JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 : S47 - S48
[40] Gabapentin: Pharmacokinetics, efficacy, safety and tolerability
McLean, MJ
DRUGS OF TODAY, 1998, 34 : 13 - 30

← 1 2 3 4 5 →